Edgewise Therapeutics, Inc. / Insider Transactions
Source | Name | Title | Transaction Date | Shares | Price | Value |
|
---|---|---|---|---|---|---|---|
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Carruthers R Michael | Chief Financial Officer |
|
|
|
| |
| Derakhshan Behrad | Chief Business Officer |
|
|
|
| |
| Donovan Joanne M. | CMO |
|
|
|
| |
| KOCH KEVIN | President and CEO |
|
|
|
| |
| MOORE JOHN R | General Counsel |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Carruthers R Michael | Chief Financial Officer |
|
|
|
| |
| Derakhshan Behrad | Chief Business Officer |
|
|
|
| |
| Donovan Joanne M. | CMO |
|
|
|
| |
| KOCH KEVIN | President and CEO |
|
|
|
| |
| MOORE JOHN R | General Counsel |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| OrbiMed Genesis GP LLC | N/A |
|
|
|
| |
| Thompson Peter A. | N/A |
|
|
|
| |
| KOCH KEVIN | President and CEO |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| KOCH KEVIN | President and CEO |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Derakhshan Behrad | Chief Business Officer |
|
|
|
| |
| Donovan Joanne M. | CMO |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Semigran Marc | Chief Development Officer |
|
|
|
| |
| MOORE JOHN R | General Counsel |
|
|
|
| |
| Carruthers R Michael | Chief Financial Officer |
|
|
|
| |
| Derakhshan Behrad | Chief Business Officer |
|
|
|
| |
| Donovan Joanne M. | CMO |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Carruthers R Michael | Chief Financial Officer |
|
|
|
| |
| Derakhshan Behrad | Chief Business Officer |
|
|
|
| |
| Donovan Joanne M. | CMO |
|
|
|
| |
| KOCH KEVIN | President and CEO |
|
|
|
| |
| MOORE JOHN R | General Counsel |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Derakhshan Behrad | Chief Business Officer |
|
|
|
| |
| MOORE JOHN R | General Counsel |
|
|
|
| |
| Carruthers R Michael | Chief Financial Officer |
|
|
|
| |
| OrbiMed Genesis GP LLC | N/A |
|
|
|
| |
| Thompson Peter A. | N/A |
|
|
|
| |
| MOORE JOHN R | General Counsel |
|
|
|
| |
| Fox Jonathan C | N/A |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Carruthers R Michael | Chief Financial Officer |
|
|
|
| |
| Derakhshan Behrad | Chief Business Officer |
|
|
|
| |
| Donovan Joanne M. | CMO |
|
|
|
| |
| KOCH KEVIN | President and CEO |
|
|
|
| |
| MOORE JOHN R | General Counsel |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| OrbiMed Genesis GP LLC | N/A |
|
|
|
| |
| Thompson Peter A. | N/A |
|
|
|
| |
| Novo Holdings A/S | N/A |
|
|
|
| |
| MOORE JOHN R | General Counsel |
|
|
|
| |
| Carruthers R Michael | Chief Financial Officer |
|
|
|
| |
| OrbiMed Genesis GP LLC | N/A |
|
|
|
| |
| Thompson Peter A. | N/A |
|
|
|
| |
| MOORE JOHN R | General Counsel |
|
|
|
| |
| MOORE JOHN R | General Counsel |
|
|
|
| |
| MOORE JOHN R | General Counsel |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Russell Alan J | Chief Scientific Officer |
|
|
|
| |
| Deerfield Private Design Fund IV, L.P. | N/A |
|
|
|
| |
| Novo Holdings A/S | N/A |
|
|
|
| |
| OrbiMed Genesis GP LLC | N/A |
|
|
|
| |
| ROOT JONATHAN D | N/A |
|
|
|
| |
| Thompson Peter A. | N/A |
|
|
|
|